DDB2 and non-small cell lung carcinoma: Upon cisplatin treatment, KD of either the DDB2 or XPC gene increased DNA damage and induced apoptosis in KRAS-mutant NSCLC cells, thereby sensitizing these cells to cisplatin treatment.